Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

After years of sparring, the Biden administration and Gilead Sciences have settled a contentious lawsuit over patents for a ...

Gilead Sciences (GILD) has reportedly settled a patent lawsuit with the federal government over its HIV drugs Truvada and ...

Biotech dealmaking is back — but smaller and more intimate. Deals disclosed in the early days of the new year indicate that ...

J&J, GSK, Eli Lilly and others struck high-value transactions in the early days of biopharma’s annual kickoff conference.

As the year gets underway, analysts and biotech executives highlight cell therapy’s pivot from oncology to autoimmune ...